Zegocractin
N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro-6-methylbenzamide
Molecular Identity
Zegocractin
N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro-6-methylbenzamide
PubChem CID: 122507647
2D Structure
Properties
C19H11ClF3N3O3
Molecular Formula
421.80
Molecular Weight
g/mol
421.0441
Exact Mass
Da
4.3
XLogP
Drug-like (Lipinski: < 5)
73.3
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
616
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Zegocractin1713240-67-5CM-4620CM4620CM 4620564AW1RR37N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro-6-methylbenzamideN-(5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamideRefChem:195905CRAC Inhibitor CM4620Orai1 Inhibitor CM4620CM128CM-128Orai Ca2+ Channel Inhibitor CM4620Calcium Release-activated Channel Inhibitor CM4620
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Zegocractin
Loading drug network...